MedTrace Logo

Connect® MM- The Multiple Myeloma Disease Registry

NCT01081028 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3011

Last updated 2026-04-13

No results posted yet for this study

Summary

The purpose of the Connect® MM Registry is to explore the natural history and real world management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide unique insights into the management of MM and the impact of this hematologic disorder on patients.

Conditions

Interventions

OTHER

First-line therapy

As prescribed by treating physician

DRUG

Second-line Multiple Myeloma treatments

As prescribed by the treating physician

Sponsors & Collaborators

  • Celgene

    lead INDUSTRY

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01081028 on ClinicalTrials.gov